Skip to main content

Atlas Venture — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

115
Companies
$5.1B
Total invested
$62.8M
Avg. check
54
Industries
Biotechnology 9Software 6Health Care 6Medical 5Analytics 5SaaS 5+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 115
Skillz
December 2020

Skillz is a marketplace platform for competition-based mobile games.

Developer Platform · Las Vegas$159.0M Post Ipo Equity
Aerovate Therapeutics
August 2020

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

Biotechnology · Boston$72.6M Series A
Surface Oncology
May 2020

Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.

Biotechnology · Cambridge$28.9M Post Ipo Equity
Opera Event
April 2020

Influencer Infrastructure for Social Media

Cryptocurrency · San Francisco$5.0M Series A
Quench Bio
January 2020

Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.

Biotechnology · Cambridge$50.0M Series A
Translate Bio
January 2020

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

Biotechnology · Lexington$125.0M Post Ipo Equity
Triplet Therapeutics
December 2019

Triplet is developing transformative therapies that treat repeat expansion disorders at their source.

Biotechnology · Cambridge$49.0M Series A
IFM Therapeutics
December 2019

DescriptionIFM Therapeutics is a pharmaceutical company focused on developing biological treatments for autoimmune diseases.

Biopharma · Boston$55.5M Series Unknown
Medical Information Solutions
February 2019

Medical Information Solutions is developing mobile services for doctors and patients.

Health Care · Moscow$820K Series A
InsightSquared
May 2018

InsightSquared is a revenue intelligence platform that provides sales intelligence solutions for forecasting, accuracy, and decision-making.

Analytics · Boston$23.0M Series D
Rodin Therapeutics
September 2017

Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.

Biotechnology · Cambridge$27.0M Series C
Indalo Therapeutics
August 2017

Indalo Therapeutics is a preclinical-stage biotechnology company.

Biotechnology · St Louis$9.0M Series Unknown
Sqrrl
June 2017

Sqrrl provides a big data analytic tool for detecting, investigating, and visualizing advanced cybersecurity threats.

Analytics · Cambridge$12.3M Series C
SimpleReach
April 2017

SimpleReach is a content data cloud for brands to measure and improve content ROI.

Analytics · New York$13.6M Series B
ZappRx
April 2017

ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are ordered

Health Care · Boston$25.0M Series B
Ready4
February 2017

Ready4 aims to create the world's most advanced mobile learning platform and connect students to opportunity.

EdTech · BostonSeries A
Delinia
September 2016

Delinia was founded to discover and develop novel therapeutics for the treatment of autoimmune and inflammatory diseases.

Biotechnology · San Francisco$35.0M Series A
Spindle
June 2016

Spindle is a geo-restricted mobile app that provides information and updates on public events and places shared in Facebook and Twitter.

Events · Boston$1.2M Series Unknown
Appcito
March 2016

Appcito accelerates multi-cloud adoption with a transformative application delivery solution for new age application architectures.

Cloud Management · Santa Clara$7.6M Series Unknown
Vidado
January 2016

Vidado is an AI platform designed to help enterprise businesses extract and digitize otherwise-inaccessible data.

Artificial Intelligence (AI) · Oakland$35.0M Series C
Mobee
August 2015

Mobee App is a mobile app.

E-Commerce · San Mateo$5.0M Series A
Nutonian
June 2015

Nutonian's A.I.-powered modeling engine, Eureqa, automatically analyzes structured data to build the most accurate and actionable models.

Analytics · BostonNon Equity Assistance
Preact
June 2015

Preact is a cloud-based customer success service that helps subscription software companies maximize customer lifetime value by reducing

Analytics · San Francisco$7.0M Series Unknown
Bridj
March 2015

Bridj is a supercharged booking and fleet management platform.

Big Data · BrisbaneSeries A

Where Atlas Venture invests

Biotechnology9
Software6
Health Care6
Medical5
Analytics5
SaaS5

About Atlas Venture's portfolio

How many companies has Atlas Venture invested in?

Atlas Venture has invested in 115 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Atlas Venture invest in?

Atlas Venture's top investment sectors include Biotechnology, Software, Health Care, Medical, Analytics. The firm invests across 54 different industry categories.

What is Atlas Venture's largest investment?

Among tracked funding rounds, Skillz received $159.0M in a Post Ipo Equity round. Atlas Venture's total known invested capital is $5.1B.

What is the average investment size for Atlas Venture?

Atlas Venture's average investment size is $62.8M across its portfolio of 115 companies.

What are Atlas Venture's most recent investments?

Recent Atlas Venture portfolio additions include Skillz, Aerovate Therapeutics, Surface Oncology, Opera Event, Quench Bio. These companies were founded in 2020 or later.

Reach the founders behind these 115 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →